SEC Filing Summary: Zapata Corporation (10-Q)
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2007. Zapata Corporation is a holding company with no active operating business. Following the sale of its Omega Protein Corporation shares in December 2006, the Company holds approximately $152.5 million in cash, cash equivalents, and short-term U.S. Government securities. Zapata currently owns 98% of Zap.Com Corporation, a public shell company, and is actively searching for an acquisition target. The Company relies on a Rule 3a-2 election to avoid classification as an investment company under the Investment Company Act of 1940, an exemption expiring November 28, 2007.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2007 | Six Months Ended June 30, 2007 |
|---|---|---|
| Revenues | $0 | $0 |
| Operating Loss | $(711,000) | $(1,670,000) |
| Interest Income | $1,956,000 | $3,900,000 |
| Net Income (Continuing Ops) | $686,000 | $1,152,000 |
| Net Income (Total) | $686,000 | $1,152,000 |
| Diluted EPS | $0.04 | $0.06 |
| Cash and Equivalents | $133,544,000 (as of June 30, 2007) | |
| Short-Term Investments | $18,999,000 (as of June 30, 2007) | |
| Total Liabilities | $3,524,000 (as of June 30, 2007) |
Material Changes vs. Prior Period
- Profitability: The Company reported a net income of $686,000 for the quarter, compared to a net loss of $359,000 in the same period of 2006. This reversal is primarily due to increased interest income and reduced operating expenses.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses decreased significantly to $711,000 (Q2 2007) from $2.0 million (Q2 2006). The prior year included $831,000 in health benefits and $123,000 in consulting fees for former Chairman Malcolm Glazer, which were not incurred in the current period.
- Interest Income: Interest income rose to $1.96 million (Q2 2007) from $917,000 (Q2 2006), driven by higher interest rates and increased cash balances following the Omega Protein divestiture.
- Discontinued Operations: The prior year included income from discontinued operations (Omega Protein). No such income was recorded in 2007 as the sale closed in late 2006.
- Tax Rate: The effective tax rate increased to 46% (Q2 2007) from 34% (Q2 2006), largely due to a provision for a 15% tax on undistributed personal holding company income.
Outlook, Risks, and Contingencies
- Acquisition Strategy: Management is searching for an acquisition candidate but has not entered into any agreements. The Company may raise capital via equity or debt issuance to fund a transaction.
- Investment Company Status: A primary risk is the potential classification as an investment company under the 1940 Act if the Rule 3a-2 exemption is not extended or if the Company fails to acquire an operating business. Registration would impose significant restrictions on borrowing, stock issuance, and operations.
- Environmental Contingency: Zapata faces a claim from Weatherford International for approximately $200,000 regarding environmental cleanup at former properties. Zapata has accrued $100,000 and is vigorously defending the claim, though future costs could exceed this reserve.
- Liquidity: The Company maintains strong liquidity with over $150 million in cash and investments, sufficient to fund operations for at least the next 12 months.
Investor Verification Checklist
- Verify the status of the Rule 3a-2 exemption election and the timeline for seeking an extension from the SEC.
- Confirm the Company's progress in identifying and negotiating potential acquisition targets.
- Monitor the resolution of the Weatherford International environmental claim and any potential for increased accruals.
- Review the composition of short-term investments to ensure they remain compliant with the Company's non-investment company stance.
- Assess the impact of the personal holding company tax provision on future cash flows if no acquisition occurs.